(Kureczka/Martin Associates) A nonabsorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage. The results suggest the compound, a high molecular weight co-polymer of polyethylene glycol (PEG), may provide a new way to prevent serious GI side effects of radiation in patients receiving fractionated radiotherapy for abdominal cancers or in accidental exposures to harmful radiation.
Read the full story here...
EurekAlert offers several feeds for breaking science news headlines. As part of the Reactive Reports chemistry news aggregation service, otherwise known as Reactor, we offer the chemistry, materials, nano and related feed here for RR readers. You can find out more about Eurekalert here.
If you're lucky, the following quote may be relevant in some way to the post above, but then again...

Popular Posts